-+ 0.00%
-+ 0.00%
-+ 0.00%

Innovative Cellular Therapeutics Holdings reports Lyell Immunopharma common share disposal worth $137.3

PUBT·07/18/2026 01:45:52
Listen to the news
Innovative Cellular Therapeutics Holdings reports Lyell Immunopharma common share disposal worth $137.3
  • Lyell Immunopharma 10% owner Innovative Cellular Therapeutics Holdings Ltd sold 10 common shares on July 16, 2026.
  • Shares were sold at USD 13.73, cutting holdings to 2,857,490 common shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lyell Immunopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-028846), on July 17, 2026, and is solely responsible for the information contained therein.